United States · FDA National Drug Code directory
Irbesartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-327_1f98fd95-e564-45b3-947f-45eba77f2af5
- Product NDC
- 72205-327
- Form
- TABLET, FILM COATED
- Composition / generic term
- Irbesartan
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251104
- Source listing expiry
- 20261231
Source-listed ingredients
- IRBESARTAN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (72205-327-05) · 72205-327-05
- 10 BLISTER PACK in 1 CARTON (72205-327-06) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 72205-327-06
- 30 TABLET, FILM COATED in 1 BOTTLE (72205-327-30) · 72205-327-30
- 90 TABLET, FILM COATED in 1 BOTTLE (72205-327-90) · 72205-327-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (72205-327-99) · 72205-327-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →